Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection

K.C. Pharmaceuticals, a California company, has recalled more than 3.1 million bottles of lubricating eye drops because they were not properly tested for sterility. The recall, initiated on March 3, 2026, affects eight products sold under various names at major retailers like Walgreens and CVS. This issue is significant as using nonsterile eye drops can cause severe eye infections, though no infections have been reported as of early April. This marks the second time since 2023 the FDA has noted sterility issues at K.C. Pharmaceuticals, previously issuing a warning letter regarding microbiological contamination. Consumers who purchased affected products should stop using them and return them for a refund, and seek medical attention if symptoms of an eye infection appear.